ArticleMolecular biology reports2026
4-Phenylbutyric acid attenuates endoplasmic reticulum stress-mediated polystyrene microplastic-induced nephrotoxicity in Wistar rats.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPlastics are considered as the most significant global environmental concerns. Previous studies have found that microplastics can accumulate in blood and various tissues, causing reproductive, neurotoxic, and hepatotoxic effects, among others, through multiple mechanisms. The present study aims to elucidate the ameliorative role of 4-PBA against polystyrene microplastics (PSMPs)-induced nephrotoxicity. METHODS AND
resultsA total of twenty-four female Wistar rats were randomly assigned to four experimental groups (each group, n = 6). The first group consisted of healthy female Wistar rats. Rats in the second group received PSMPs (10 mg/kg) orally for five weeks. The third group received PSMPs for five weeks and 4-PBA (500 mg/kg) orally for the last two weeks of the study. The last group was treated with PSMPs and 4-PBA (1000 mg/kg) for five and the last two weeks, respectively. After five weeks, animals were euthanised, and kidney tissues and blood samples were collected immediately. Compared with normal control rats, animals treated with PSMPs showed a substantial rise with a percentage change in serum BUN (32.44%), creatinine (74.69%), MDA (11.62%), and nitrite (152.45%), and decreases in body weight (24.60%), kidney weight (23.96%), and GSH (64.41%). Additionally, the PSMPs group exhibited notable abnormalities in kidney histopathology. ER stress biomarkers, including GRP78 (163.23%), CHOP (363.72%), and caspase-12 (310.29%), were also found to be increased in the PSMPs group. On the other hand, 4-PBA alleviated histological abnormalities and improved biochemical indicators, as well as the expression of ER stress markers in kidney tissues.
conclusionThe above-mentioned results suggest that 4-PBA may be a therapeutic agent against ER stress-mediated PSMPs-induced nephrotoxicity in rats.
Indexed as
Identifiers
42474835What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.